CEO of New Generic Pharmaceutical Subscription Service Speaks About High Retail Prices and FTC Investigation

AKRON, Ohio, June 15, 2022 (Newswire.com) - Doug Behrens, CEO of MyFreePharmacy, a monthly subscription service for generic prescription drugs, released a statement today responding to higher prices being paid for generic prescription drugs and the recent FTC investigation into the role played by the middlemen companies in increasing the cost of prescription drugs in the U.S.

"Prescription drug prices have skyrocketed over the last few years to the point where some people can no longer afford them. There are a lot of additional costs passed on to the consumer today from a highly inefficient supply chain. MyFreePharmacy is among the companies trying to disrupt this system and correct these problems. We believe that you shouldn't have to choose between feeding your family or taking your medications." — Doug Behrens, CEO, MyFreePharmacy.

About MyFreePharmacy

Many Americans are currently being overcharged for their generic prescriptions and often worry about how to pay for them. MyFreePharmacy offers more than 600 medications for one low monthly fee (including free shipping) to end these worries and make medicine more affordable. For more information, please visit www.myfreepharmacy.com/join.

CONTACT:
Scott Robertson, APR
RobertsonComm for MyFreePharmacy
480-744-5622
scott@robertsoncomm.com

Source: MyFreePharmacy